186 related articles for article (PubMed ID: 26943017)
1. Modulation of Hematopoietic Chemokine Effects In Vitro and In Vivo by DPP-4/CD26.
Broxmeyer HE; Capitano M; Campbell TB; Hangoc G; Cooper S
Stem Cells Dev; 2016 Apr; 25(8):575-85. PubMed ID: 26943017
[TBL] [Abstract][Full Text] [Related]
2. AMD3100 and CD26 modulate mobilization, engraftment, and survival of hematopoietic stem and progenitor cells mediated by the SDF-1/CXCL12-CXCR4 axis.
Broxmeyer HE; Hangoc G; Cooper S; Campbell T; Ito S; Mantel C
Ann N Y Acad Sci; 2007 Jun; 1106():1-19. PubMed ID: 17360804
[TBL] [Abstract][Full Text] [Related]
3. Stromal cell-derived factor-1/CXCL12 selectively counteracts inhibitory effects of myelosuppressive chemokines on hematopoietic progenitor cell proliferation in vitro.
Broxmeyer HE; Cooper S; Hangoc G; Kim CH
Stem Cells Dev; 2005 Apr; 14(2):199-203. PubMed ID: 15910246
[TBL] [Abstract][Full Text] [Related]
4. Cell surface peptidase CD26/DPPIV mediates G-CSF mobilization of mouse progenitor cells.
Christopherson KW; Cooper S; Broxmeyer HE
Blood; 2003 Jun; 101(12):4680-6. PubMed ID: 12576320
[TBL] [Abstract][Full Text] [Related]
5. The role of dipeptidyl peptidase 4 in hematopoiesis and transplantation.
O'Leary H; Ou X; Broxmeyer HE
Curr Opin Hematol; 2013 Jul; 20(4):314-9. PubMed ID: 23594692
[TBL] [Abstract][Full Text] [Related]
6. Dipeptidylpeptidase 4 negatively regulates colony-stimulating factor activity and stress hematopoiesis.
Broxmeyer HE; Hoggatt J; O'Leary HA; Mantel C; Chitteti BR; Cooper S; Messina-Graham S; Hangoc G; Farag S; Rohrabaugh SL; Ou X; Speth J; Pelus LM; Srour EF; Campbell TB
Nat Med; 2012 Dec; 18(12):1786-96. PubMed ID: 23160239
[TBL] [Abstract][Full Text] [Related]
7. G-CSF- and GM-CSF-induced upregulation of CD26 peptidase downregulates the functional chemotactic response of CD34+CD38- human cord blood hematopoietic cells.
Christopherson KW; Uralil SE; Porecha NK; Zabriskie RC; Kidd SM; Ramin SM
Exp Hematol; 2006 Aug; 34(8):1060-8. PubMed ID: 16863912
[TBL] [Abstract][Full Text] [Related]
8. CD26 inhibition and hematopoiesis: a novel approach to enhance transplantation.
Campbell TB; Broxmeyer HE
Front Biosci; 2008 Jan; 13():1795-805. PubMed ID: 17981668
[TBL] [Abstract][Full Text] [Related]
9. Cyclin dependent kinase inhibitors differentially modulate synergistic cytokine responsiveness of hematopoietic progenitor cells.
Broxmeyer HE; Franklin DS; Cooper S; Hangoc G; Mantel C
Stem Cells Dev; 2012 Jul; 21(10):1597-603. PubMed ID: 21936707
[TBL] [Abstract][Full Text] [Related]
10. Leukemia Inhibitory Factor Promotes Survival of Hematopoietic Progenitors Ex Vivo and Is Post-Translationally Regulated by DPP4.
Ropa J; Cooper S; Broxmeyer HE
Stem Cells; 2022 Mar; 40(3):346-357. PubMed ID: 35293568
[TBL] [Abstract][Full Text] [Related]
11. Dipeptidyl Peptidase-4 Regulates Hematopoietic Stem Cell Activation in Response to Chronic Stress.
Zhu E; Hu L; Wu H; Piao L; Zhao G; Inoue A; Kim W; Yu C; Xu W; Bando YK; Li X; Lei Y; Hao CN; Takeshita K; Kim WS; Okumura K; Murohara T; Kuzuya M; Cheng XW
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28710180
[TBL] [Abstract][Full Text] [Related]
12. DPP4 truncated GM-CSF and IL-3 manifest distinct receptor-binding and regulatory functions compared with their full-length forms.
O'Leary HA; Capitano M; Cooper S; Mantel C; Boswell HS; Kapur R; Ramdas B; Chan R; Deng L; Qu CK; Broxmeyer HE
Leukemia; 2017 Nov; 31(11):2468-2478. PubMed ID: 28344320
[TBL] [Abstract][Full Text] [Related]
13. Synergistic inhibition in vivo of bone marrow myeloid progenitors by myelosuppressive chemokines and chemokine-accelerated recovery of progenitors after treatment of mice with Ara-C.
Broxmeyer HE; Pelus LM; Kim CH; Hangoc G; Cooper S; Hromas R
Exp Hematol; 2006 Aug; 34(8):1069-77. PubMed ID: 16863913
[TBL] [Abstract][Full Text] [Related]
14. Class II transactivator-mediated regulation of major histocompatibility complex class II antigen expression is important for hematopoietic progenitor cell suppression by chemokines and iron-binding proteins.
Broxmeyer HE; Cooper S; Hangoc G; Chang CH
Exp Hematol; 2006 Aug; 34(8):1078-84. PubMed ID: 16863914
[TBL] [Abstract][Full Text] [Related]
15. Kinetic investigation of chemokine truncation by CD26/dipeptidyl peptidase IV reveals a striking selectivity within the chemokine family.
Lambeir AM; Proost P; Durinx C; Bal G; Senten K; Augustyns K; Scharpé S; Van Damme J; De Meester I
J Biol Chem; 2001 Aug; 276(32):29839-45. PubMed ID: 11390394
[TBL] [Abstract][Full Text] [Related]
16. CD26/dipeptidylpeptidase IV-chemokine interactions: double-edged regulation of inflammation and tumor biology.
Mortier A; Gouwy M; Van Damme J; Proost P; Struyf S
J Leukoc Biol; 2016 Jun; 99(6):955-69. PubMed ID: 26744452
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of DPP4/CD26 and dmPGE₂ treatment enhances engraftment of mouse bone marrow hematopoietic stem cells.
Broxmeyer HE; Pelus LM
Blood Cells Mol Dis; 2014; 53(1-2):34-8. PubMed ID: 24602918
[TBL] [Abstract][Full Text] [Related]
18. A novel anti-inflammatory function of human galectin-1: inhibition of hematopoietic progenitor cell mobilization.
Kiss J; Kunstár A; Fajka-Boja R; Dudics V; Tóvári J; Légrádi A; Monostori E; Uher F
Exp Hematol; 2007 Feb; 35(2):305-13. PubMed ID: 17258079
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of DPP4 activity in humans establishes its in vivo role in CXCL10 post-translational modification: prospective placebo-controlled clinical studies.
Decalf J; Tarbell KV; Casrouge A; Price JD; Linder G; Mottez E; Sultanik P; Mallet V; Pol S; Duffy D; Albert ML
EMBO Mol Med; 2016 Jun; 8(6):679-83. PubMed ID: 27137491
[TBL] [Abstract][Full Text] [Related]
20. Modulation of hematopoietic stem cell homing and engraftment by CD26.
Christopherson KW; Hangoc G; Mantel CR; Broxmeyer HE
Science; 2004 Aug; 305(5686):1000-3. PubMed ID: 15310902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
